Literature DB >> 17717488

N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.

Brigitte Meyer1, Martin Huelsmann, Paul Wexberg, Georg Delle Karth, Rudolf Berger, Deddo Moertl, Thomas Szekeres, Richard Pacher, Gottfried Heinz.   

Abstract

OBJECTIVES: Natriuretic peptides emerged during recent years as potent prognostic markers in patients with heart failure and acute myocardial infarction. In addition, natriuretic peptides show strong predictive value in patients with pulmonary embolism, sepsis, renal failure, and shock. The present study tests the prognostic information of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in an unselected cohort of critically ill patients.
DESIGN: Prospective, observational study.
SETTING: A tertiary intensive care unit in a university hospital. PATIENTS: A total of 289 consecutive patients admitted to the intensive care unit during a 16-month period with the following data: age 64 +/- 14 yrs, male n = 191, Simplified Acute Physiology Score II of 52 +/- 24, mechanical ventilation n = 180 (62%), vasopressors n = 179 (62%), renal failure n = 24 (8%).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Plasma NT-pro-BNP samples (Roche Diagnostics) were obtained on intensive care unit admission. Data are given as median [range]. Intensive care unit survivors had significantly lower NT-pro-BNP values compared with intensive care unit nonsurvivors (3394 [24-35,000] vs. 6776 [303-35,000] pg/mL, survivors vs. nonsurvivors, respectively, p = .001). Hospital survivors were characterized by significantly lower NT-pro-BNP values (2656 [24-35,000] vs. 8390 [303-35,000] pg/mL, survivors vs. nonsurvivors, respectively, p = .001). NT-pro-BNP levels were not significantly different in patients with primary cardiac diagnosis compared with those with a noncardiac admission diagnosis (4794 [26-35,000], n = 202 vs. 3349 [24-35,000], n = 87, cardiac vs. noncardiac, respectively, p = .28). In a logistic regression model, Simplified Acute Physiology Score II and NT-pro-BNP were independently associated with hospital survival (chi = 35.6, p = .0001 and chi = 11.3, p = .0008, Simplified Acute Physiology Score II and NT-pro-BNP, respectively). Areas under the receiver operating characteristic curves of NT-pro-BNP and Simplified Acute Physiology Score II were not statistically significant different regarding the prediction of outcome.
CONCLUSIONS: NT-pro-BNP on admission is an independent prognostic marker of outcome in an unselected cohort of critically ill patients. A single measurement of NT-pro-BNP might facilitate triage of emergency and intensive care unit patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717488     DOI: 10.1097/01.CCM.0000284509.23439.5B

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  29 in total

1.  Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.

Authors:  C Lüers; A Schmidt; R Wachter; F Fritzsche; A Sutcliffe; S Kleta; A Zapf; G Hagenah; L Binder; B Maisch; B Pieske
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

Review 2.  [Cardiac biomarkers in the critically ill].

Authors:  S Reith; N Marx
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-01-06       Impact factor: 0.840

3.  Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.

Authors:  Kyuri Kim; Naseem Chini; David G Fairchild; Steven K Engle; William J Reagan; Sandra D Summers; Jon C Mirsalis
Journal:  Toxicol Pathol       Date:  2016-09-28       Impact factor: 1.902

4.  Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.

Authors:  Juliana Jensen; Li-Ping Ma; Michael L X Fu; David Svaninger; Per-Arne Lundberg; Ola Hammarsten
Journal:  Clin Res Cardiol       Date:  2010-03-13       Impact factor: 5.460

5.  Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma.

Authors:  A Qian; M Zhang; G Zhao
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-03       Impact factor: 3.693

6.  The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.

Authors:  Guangxi Li; Craig E Daniels; Marija Kojicic; Tami Krpata; Greg A Wilson; Jeffrey L Winters; S Breanndan Moore; Ognjen Gajic
Journal:  Transfusion       Date:  2008-10-14       Impact factor: 3.157

7.  B-type natriuretic levels in critically ill patients: critically misleading?

Authors:  Hisham Dokainish
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

Review 8.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 9.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.